<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">rsp</journal-id><journal-title-group><journal-title xml:lang="ru">Научно-практическая ревматология</journal-title><trans-title-group xml:lang="en"><trans-title>Rheumatology Science and Practice</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1995-4484</issn><issn pub-type="epub">1995-4492</issn><publisher><publisher-name>IMA-PRESS, LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.14412/1995-4484-2002-68</article-id><article-id custom-type="elpub" pub-id-type="custom">rsp-411</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>Articles</subject></subj-group></article-categories><title-group><article-title>ОТДАЛЕННЫЙ ПРОГНОЗ ПОДОСТРОГО ИНФЕКЦНОННОГО ЭНДОКАРДИТА</article-title><trans-title-group xml:lang="en"><trans-title>FOLLOW-UP PROGNOSIS OF SUBACUTE INFECTIOUS ENDOCA RDITIS</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Kulichenko</surname><given-names>V P</given-names></name><name name-style="western" xml:lang="en"><surname>Kulichenko</surname><given-names>V P</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Vinogradova</surname><given-names>T L</given-names></name><name name-style="western" xml:lang="en"><surname>Vinogradova</surname><given-names>T L</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Chipigina</surname><given-names>N S</given-names></name><name name-style="western" xml:lang="en"><surname>Chipigina</surname><given-names>N S</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Shosiak</surname><given-names>N A</given-names></name><name name-style="western" xml:lang="en"><surname>Shosiak</surname><given-names>N A</given-names></name></name-alternatives><email xlink:type="simple">-</email></contrib></contrib-group><pub-date pub-type="collection"><year>2002</year></pub-date><pub-date pub-type="epub"><day>15</day><month>04</month><year>2002</year></pub-date><volume>40</volume><issue>2</issue><issue-title>№2 (2002)</issue-title><fpage>1</fpage><lpage>1</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Kulichenko V.P., Vinogradova T.L., Chipigina N.S., Shosiak N.A., 2002</copyright-statement><copyright-year>2002</copyright-year><copyright-holder xml:lang="ru">Kulichenko V.P., Vinogradova T.L., Chipigina N.S., Shosiak N.A.</copyright-holder><copyright-holder xml:lang="en">Kulichenko V.P., Vinogradova T.L., Chipigina N.S., Shosiak N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://rsp.mediar-press.net/rsp/article/view/411">https://rsp.mediar-press.net/rsp/article/view/411</self-uri><abstract><p>Цель, Изучить отдаленный прогноз подострого инфекционного эндокардита (ИЭ): выявить факторы, достоверно влияющие на прогноз и сформулировать подходы к его оценке. Материал и методы. Проведено ретроспективное исследование, в которое включены 98 пациентов, выписанных из стационара с диагнозом подострый ИЭ. Условие включения - отсутствие оперативного лечения и/или эндокардита клапанного протеза. У всех больных диагноз подтвержден при Эхо-КГ. Прослежен исход больных (средний срок наблюдения 4,8 + 3,7 г) и проведена оценка клинических и Эхо-КГ данных. При анализе результатов и построении прогностического правила использованы программные средства. Результаты. 5-летняя летальность составила 31%. Причины смерти: сердечная недостаточность (СН) у 21(84%), острое нарушение мозгового кровообращения (ОНМК) — у 4(16%) больных. У выживших пациентов поздними осложнениями были: выраженная СН у 18(32%), умеренная СН у 18(32%), рецидивы ИЭ у 12(20%) больных. Факторами, достоверно влияющими на отдаленный прогноз, явились: вариант ИЭ (первичный или вторичный), поражение аортального клапана, выраженность регургитации, размеры левого желудочка, степень прогрессирования СН во время острой фазы и ряд других факт оров, показавших информативность в предложенном методе комплексной оценки прогноза. Заключение. Основным отдаленным осложнением ИЭ и причиной смерти является СН; темпы ее прогрессирования определяются сочетанием указанных факторов. Больные группы высокого риска должны быть консультированы кардиохирургом до развития СН.</p></abstract><trans-abstract xml:lang="en"><p>Objective. To study follow-up prognosis of subacule infectious endocarditis (IE); to reveal factors reliably influencing prognosis; to formulate approaches to its assessment. Material and methods. Retrospective study was carried out which included 98 pts relieved from the hospital with diagnosis «Subaculc 1Е». Condition of including-absence of wurgical treatment or endocarditis of prosthelis. In all pts the diagnosis was confirmed by echo-CG. In all pts the diagnosis was confirmed by Echo-CG. The prognosis of pts was followed; in dynamiacs (median term of follow up 4,8±3,7 yrs) assessment of clinical and ECG data was done. Analysis of data and forming of prognostic rule was done by database means. Results. 5-year mortality was 31%. Reasons for mortality: cardiac insufficiency (Cl) in 21 (84%), acute insufficiency of mitral valve in 4(16%) of pts. In the survived late exacerbations were: expressed Cl in 18(32%), moderate Cl in 18(32%), relapses of infectious endocarditis in 12(20%) of pts. Factors reliably influencing log-term prognosis were: IE (primary or secondare), damage of aortal valve, severe regurgitation, dimensions of left ventricle, the stage of Cl progression during acute phase and a number of other factors demonstrating informativity and proposed method of combined assessment of prognosis. Conchtsion. Cl was a basic long-term complication and reason of death; speed of its progress are determined by the combination of pointed factors. Pts from the group of high risk should have consults of cardiosurgeon prior to development of Cl.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>инфекционный эндокардит</kwd><kwd>летальность</kwd><kwd>прогнозирование</kwd></kwd-group><kwd-group xml:lang="en"><kwd>infectious endocarditis</kwd><kwd>mortality</kwd><kwd>prognosis</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">&lt;div&gt;&lt;p&gt;Алехин М. Н., Седов В. П. Допплер- эхокардмографня. М. 1997,&lt;/p&gt;&lt;p&gt;Буткевич О. М., Виноградова Т. JT. Инфекционный эндокардит. М., 1998.&lt;/p&gt;&lt;p&gt;Ребров А. П., Пономарева Е. Ю., Белова А. А., Кароли М. А. Инфекционный эндокардит: качество диагностики и клинические особенности. Тер. арх., 2000, 9, 50 - S3.&lt;/p&gt;&lt;p&gt;Тазина С. Я., Гуревич М. А. Современный инфекционный эндокардит. Клин, мед., 1999, 12, 19 -22.&lt;/p&gt;&lt;p&gt;Асаг J, Michel P. L., Varenne О. et al. Surgical treatment of infective endocarditis. Eur. Heart J., 1995,16, suppl B, 94 - 98.&lt;/p&gt;&lt;p&gt;ACC/AHA Guidelines for the management of patients with valvular heart disease.). Am. Coll. Cardiol., 1998, 32, I486 - 1588.&lt;/p&gt;&lt;p&gt;Bonow R. O. Chronic aortic regurgitation. Role of medical therapy and optimal liming for surgery. Cardiol. Clin., 1998, 16(3), 449-461.&lt;/p&gt;&lt;p&gt;Carabello B. A. The changing unnatural history of valvular regurgitation, Ann, Tliorac. Surg,, 1992, 53, 191 - 199.&lt;/p&gt;&lt;p&gt;CasLillo J.C., Anguita M P,, Ramirez A et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart, 2000, 83, 525 - 530.&lt;/p&gt;&lt;p&gt;De Castro S. Magni G., Bern S. et al. Role of translhoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am. J. Cardiol., 1997, 80(8), 1030-1034.&lt;/p&gt;&lt;p&gt;Erbcl R, Liu F, Gc J. it al. Identilication of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur. Heart J., 1995,16(5), 588-602.&lt;/p&gt;&lt;p&gt;Feigenbaum H. Echocardiography. 5th ed., Baltimore, Williams &amp;amp; Wilkins., 1994.&lt;/p&gt;&lt;p&gt;Karalis D., Blumbcrg E., Vilaro J. et al. Prognostic significance of valvular regurgitation in patients with infective endocarditis. Am. Heart J., 1991, 90, 193 - 197.&lt;/p&gt;&lt;p&gt;Korchmer A. Infective endocarditis. In: Braunwald E. Heart Disease. 5th ed. Phyladclphia, W B. Saunders Company. 1997, 1077-1099,&lt;/p&gt;&lt;p&gt;Sanfilippo A. J., Picard М. H., Newell J. I), et al. Echocardio- graphie assessment of patients with infectious endocarditis: prediction of risk for complications. J. Am. Coll. Cardiol., 1991, 18, 1191 - 1199.&lt;/p&gt;&lt;p&gt;Tarasoulchi F., Grinberg М. Filho J. P. et al. Symptoms, lefl ventricular function, and timing of valve replacement surgery in patients with aortic regurgitation. Am, Heart J., 1999, 138 (3 Pi I), 477-485,&lt;/p&gt;&lt;p&gt;Tornos М. P , Olona M, Permanyer-Miralda G. et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am. Heart J. 1995, 130(2), 333-339.&lt;/p&gt;&lt;p&gt;Vahl C.F., Kloss Т., Yang Y. et al. Surgical treatment of oligo- symploinalic mitral valve incompetence? Eur. J. Cardiotho- rac. Surg., 1999, 16, 524-532.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation><mixed-citation xml:lang="en">&lt;div&gt;&lt;p&gt;Алехин М. Н., Седов В. П. Допплер- эхокардмографня. М. 1997,&lt;/p&gt;&lt;p&gt;Буткевич О. М., Виноградова Т. JT. Инфекционный эндокардит. М., 1998.&lt;/p&gt;&lt;p&gt;Ребров А. П., Пономарева Е. Ю., Белова А. А., Кароли М. А. Инфекционный эндокардит: качество диагностики и клинические особенности. Тер. арх., 2000, 9, 50 - S3.&lt;/p&gt;&lt;p&gt;Тазина С. Я., Гуревич М. А. Современный инфекционный эндокардит. Клин, мед., 1999, 12, 19 -22.&lt;/p&gt;&lt;p&gt;Асаг J, Michel P. L., Varenne О. et al. Surgical treatment of infective endocarditis. Eur. Heart J., 1995,16, suppl B, 94 - 98.&lt;/p&gt;&lt;p&gt;ACC/AHA Guidelines for the management of patients with valvular heart disease.). Am. Coll. Cardiol., 1998, 32, I486 - 1588.&lt;/p&gt;&lt;p&gt;Bonow R. O. Chronic aortic regurgitation. Role of medical therapy and optimal liming for surgery. Cardiol. Clin., 1998, 16(3), 449-461.&lt;/p&gt;&lt;p&gt;Carabello B. A. The changing unnatural history of valvular regurgitation, Ann, Tliorac. Surg,, 1992, 53, 191 - 199.&lt;/p&gt;&lt;p&gt;CasLillo J.C., Anguita M P,, Ramirez A et al. Long term outcome of infective endocarditis in patients who were not drug addicts: a 10 year study. Heart, 2000, 83, 525 - 530.&lt;/p&gt;&lt;p&gt;De Castro S. Magni G., Bern S. et al. Role of translhoracic and transesophageal echocardiography in predicting embolic events in patients with active infective endocarditis involving native cardiac valves. Am. J. Cardiol., 1997, 80(8), 1030-1034.&lt;/p&gt;&lt;p&gt;Erbcl R, Liu F, Gc J. it al. Identilication of high-risk subgroups in infective endocarditis and the role of echocardiography. Eur. Heart J., 1995,16(5), 588-602.&lt;/p&gt;&lt;p&gt;Feigenbaum H. Echocardiography. 5th ed., Baltimore, Williams &amp;amp; Wilkins., 1994.&lt;/p&gt;&lt;p&gt;Karalis D., Blumbcrg E., Vilaro J. et al. Prognostic significance of valvular regurgitation in patients with infective endocarditis. Am. Heart J., 1991, 90, 193 - 197.&lt;/p&gt;&lt;p&gt;Korchmer A. Infective endocarditis. In: Braunwald E. Heart Disease. 5th ed. Phyladclphia, W B. Saunders Company. 1997, 1077-1099,&lt;/p&gt;&lt;p&gt;Sanfilippo A. J., Picard М. H., Newell J. I), et al. Echocardio- graphie assessment of patients with infectious endocarditis: prediction of risk for complications. J. Am. Coll. Cardiol., 1991, 18, 1191 - 1199.&lt;/p&gt;&lt;p&gt;Tarasoulchi F., Grinberg М. Filho J. P. et al. Symptoms, lefl ventricular function, and timing of valve replacement surgery in patients with aortic regurgitation. Am, Heart J., 1999, 138 (3 Pi I), 477-485,&lt;/p&gt;&lt;p&gt;Tornos М. P , Olona M, Permanyer-Miralda G. et al. Clinical outcome of severe asymptomatic chronic aortic regurgitation: a long-term prospective follow-up study. Am. Heart J. 1995, 130(2), 333-339.&lt;/p&gt;&lt;p&gt;Vahl C.F., Kloss Т., Yang Y. et al. Surgical treatment of oligo- symploinalic mitral valve incompetence? Eur. J. Cardiotho- rac. Surg., 1999, 16, 524-532.&lt;/p&gt;&lt;/div&gt;&lt;br /&gt;</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
